Online Makale
Online Hizmetlere Toplu BakışJournal of Clinical Research in Pediatric Endocrinology
J Clin Res Pediatr Endocrinol. Baskıdaki Makaleler: JCRPE-94809 | DOI: 10.4274/jcrpe.galenos.2024.2024-3-8 | |||
Autosomal Recessive Hypophosphatemic Rickets Type 2 Associated with a Novel ENPP1 Variant in a Taiwanese GirlHan Yi Lin1, Ni Chung Lee2, Meng Ju Melody Tsai3, Ting Ming Wang4, Yi Ching Tung51Department of Pediatrics, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan2Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan 3Department of Pediatrics, National Taiwan University Hospital Yunlin Branch, Douliu, Yunlin, Taiwan 4Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei, Taiwan 5Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan Autosomal recessive hypophosphatemic rickets (HR) type 2 (ARHR2) is a rare form of HR caused by variant of the gene encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). Our patient presented with a history of unsteady gait and progressively bowing legs that had commenced at the age of 1 year. Laboratory tests revealed an elevated level of fibroblast growth factor 23 (FGF23), hypophosphatemia, and a high urine phosphate level. Radiography revealed the typical features of rickets. Next-generation sequencing identified a previously reported c.783C>G (p.Tyr261Ter) and a novel c.1092-42A>G variant in the ENPP1 gene. The patient was prescribed oral phosphates and active vitamin D and underwent guided growth of both distal femora and proximal tibiae commencing at the age of 3 years. No evidence of generalized arterial calcification was apparent during follow-up, and growth rate was satisfactory. Keywords: Encoding ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), Fibroblast growth factor 23 (FGF23), Hypophosphatemic ricketsSorumlu Yazar: Yi Ching Tung, Taiwan |
|